Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.094 | 0.07 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |